Cintas price target raised to $255 from $240 at Truist

Truist raised the firm’s price target on Cintas (CTAS) to $255 from $240 and keeps a Buy rating on the shares. The firm has increased conviction in the company’s growth algorithm after meeting with management. Cintas has a “long runway” for double-digit organic growth in its First Aid segment and can expand margins, the analyst tells investors in a research note.